The European Organ-on-Chip Society: An independent, not-for-profit organization established to encourage and develop Organ-on-Chip research.
Program with the aim to leverage the power of bioengineering to advance stem cells, organoids, and whole organ systems and connections that recapitulate human physiology in vitro and restore vital functions in vivo
Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe.
Innovative Medicines Initiative funded project that aims to develop a standard for integrated nonclinical safety overviews for immune-modulatory investigational new drugs (IND) and clinical trial applications (CTA).
The Inno4Vac project integrates AI, big data, and 3D models together creating predictive models to accelerate the process of vaccine developement.
IMPSS works towards enhancing the application of MPS in life sciences by accelerating regulatory acceptance of MPS through international collaborations and by educating the next generation of MPS scientists.
The GET-IN Network focuses on reducing knowledge gaps in gene therapy, emphasizing the optimization of scalable processes, and pioneering innovative bioengineering techniques for enhanced safety and efficacy assessments.
- Katja Schenke-Layland @ University of Tübingen and NMI
- Stefan Liebau @ University of Tübingen
- Emulate, Inc. @ Boston
- Udo Kraushaar and Peter Jones @ NMI
- Alexander Mosig @ Uniklinikum Jena
- Andreas Stahl @ UC Berkeley
- Kevin Healy @ UC Berkeley
- Nathanial Huebsch @ Washington University in St. Louis
- Bruce Conklin @ Gladstone Institutes
- Martin Weiss @ University of Tuebingen
- Anke Burger-Kentischer @ Fraunhofer IGB
- Martin Thoma @ Fraunhofer IPA
- Frank Tacke @ Charité Berlin
- Lisa Wagar @ University of California, Irvine